KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt RepaymentsR&D In ProcessShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Pfizer (PFE) Shares Issued (2016 - 2020)

Historic Shares Issued for Pfizer (PFE) over the last 9 years, with Q3 2020 value amounting to $206.0 million.

  • Pfizer's Shares Issued rose 27454.55% to $206.0 million in Q3 2020 from the same period last year, while for Sep 2020 it was $455.0 million, marking a year-over-year decrease of 172.79%. This contributed to the annual value of $425.0 million for FY2020, which is 786.8% up from last year.
  • As of Q3 2020, Pfizer's Shares Issued stood at $206.0 million, which was up 27454.55% from $34.0 million recorded in Q2 2020.
  • Pfizer's 5-year Shares Issued high stood at $625.0 million for Q3 2018, and its period low was $34.0 million during Q2 2020.
  • In the last 5 years, Pfizer's Shares Issued had a median value of $160.0 million in 2018 and averaged $205.2 million.
  • Its Shares Issued has fluctuated over the past 5 years, first crashed by 9120.0% in 2019, then skyrocketed by 27454.55% in 2020.
  • Over the past 5 years, Pfizer's Shares Issued (Quarter) stood at $73.0 million in 2016, then soared by 182.19% to $206.0 million in 2017, then dropped by 22.33% to $160.0 million in 2018, then plummeted by 43.12% to $91.0 million in 2019, then soared by 126.37% to $206.0 million in 2020.
  • Its Shares Issued was $206.0 million in Q3 2020, compared to $34.0 million in Q2 2020 and $124.0 million in Q1 2020.